Den moderne tidsalderen i psykedelisk forskning startet med en gjennombruddsstudie av Dr. Roland R. Griffiths og hans team ved Johns Hopkins School of Medicine, Baltimore i 2006.
Studie:
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Bilde fra Pixabay.
Nyheter
• These Toads Have Psychedelic Powers, but They'd Prefer to Keep It Quiet (The New York Times, 10. juli 2025)
• Ketamine helped me escape my negative thoughts - then it nearly killed me (BBC, 5. juli 2025)
• 'People pay to be told lies': the rise and fall of the world's first ayahuasca multinational (The Guardian, 3. juli 2025)
• MAPS take MDMA-Assisted Therapy to the War in Ukrain (Lucid News, 15. juni 2025)
•The Sacred Mushroom, a Sprawling Psilocybin Service Center, is Having a Bad Trip (Willamette Week, 10. mai 2025)
• Psilocybin and Neuroplasticity: A Review of Preclinical and Clinical Studies (8. mai 2025, OPEN Foundation)
• Cluster headaches are the 'most painful condition on the planet'. Sufferers are going to extreme - and secretive - measures for relief (The Guardian, 23. april 2025)
• Pirates of the Ayahuasca: That Shaman Stole My Personality (n+1, våren 2025)
• Your brain doesn't learn the way we thought, according to new neuroscience breakthrough (Psypost, 20. april 2025)
• How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy (The New York Times, 4. februar 2025)
• Medical cannabis shows potential to fight cancer, largest-ever study shows (The Guardian, 18. april 2022)
Bilde fra Pixabay.
Høydepunkter i psykedelisk forskning i år
• Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis (Translational Psychiatry, 29. august 2025) (kort norsk sammendrag)
• Long-term benefits of single-dose psilocybin in depressed patients with cancer (ACS Journals, 25. juni 2025)
• Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models (ScienceDirect, mai 2025)
• LSD Increases sleep duration the night after microdosing (Translational Psychiatry, 15. april 2025)
• Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial (ScienceDirect, april 2025)
• The Rise of Psilocybin Use in the United States: A Multisource Observational Study (Annals of Internal Medicine, 22. mars 2025)
• Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation (The Journal of Sex Research, 15. mars 2025)
• Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications (Brain Sciences, 25. januar 2025) (kort sammendrag på norsk her)
• Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants (Translational Psychiatry, 4. september) (sammendrag)
Podcaster
Serier
• Modern Psychedelics (Lana Pribic, 2021 - )
• The Drug Science Podcast with Prof. David Nutt and guests (2019 - )
Enkeltepisoder
• Children, Meaning, Media and Psychedelics (NYT, 3. september 2024)
• Faith in the Psychedelic Renaissance (BBC, 8. januar 2024)
• Pål Asdal: Psykonaut (Avhørt, 6. desember)
• America Goes Psychedelic, Again (Reveal News, 28. oktober)
• New York Magazine Cover Story: Power Trip (november, 2021 - november, 2022 )
• The Ballot Trip, City Cast Denver (juli og august 2022)
Nyttige YouTube-videoer
• JHMI - Psychedelic Risks, Side Effects, and Potential Harms (YouTube, 24.mars)
Rapporter
• Legal Risks for Providers Discussing Psychedelic Therapies (Law360, 21. mai 2025)
• Considering Alternatives to Psychedelic Drug Prohibition (Rand Foundation, juni 2023, pdf)
• Psychedelic Access Pathways: Differentiating Medical, Wellness, and Religious Access to Psychedelics (BrainFutures, juni 2023, pdf)
Nyhetsarkiv 2024
Blir du med?
Viktig informasjon --- Innholdet på disse nettsidene er ment som inspirasjon og kunnskapsdeling, ikke som erstatning for medisinsk rådgivning eller psykisk helsehjelp. Dersom du har spørsmål knyttet til helse, anbefaler vi at du snakker med kvalifisert helsepersonell som kan gi støtte og veiledning tilpasset din situasjon.
Psilocybin er i dag klassifisert som et ulovlig narkotisk stoff i Norge. Likevel er det mange som ønsker å utforske stoffet på en trygg og meningsfull måte. Pvit arbeider derfor for å fremme en ansvarlig og regulert tilnærming utenfor helsevesenet – en tilnærming der individuelle behov og valg får rom, uten krav om diagnose.
© Prosjekt Pvit 2020–2025